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which belongs to a family of novel amiloride
derivatives,  is  one  of  the  most  effective
inhibitors of Na+/H+ exchangers, while unef-
fective  against  Na+ channels  and  Na+/Ca2+
exchangers.  In  this  study,  we  provided  evi-
dence that HMA can act as a fluorescent probe.
In fact, human retinal ARPE19 cells incubated
with HMA show an intense bluish fluorescence
in the cytoplasm when observed at microscope
under conventional UV-excitation conditions.
Interestingly,  a  prolonged  observation  under
continuous  exposure  to  excitation  lightdoes
not  induce  great  changes  in  cells  incubated
with HMA for times up to about 5 min, while an
unexpected rapid increase in fluorescence sig-
nal is observed in cells incubated for longer
times. The latter phenomenon is particularly
evident in the perinuclear region and in dis-
crete spots in the cytoplasm. Since HMA mod-
ulates intracellular acidity, the dependence of
its fluorescence properties on medium pH and
response upon irradiation have been investi-
gated in solution, at pH 5.0 and pH 7.2. The
changes in both spectral shape and amplitude
emission indicate a marked pH influence on
HMA  fluorescence  properties,  making  HMA
exploitable  as  a  self  biomarker  of  pH  alter-
ations in cell studies, in the absence of pertur-
bations induced by the administration of other
exogenous dyes.
Introduction
Na+/H+ exchangers  (NHEs)  are  a  class  of
membrane  proteins  involved  in  cellular  pH
control. During the past decades, several com-
pounds belonging to the amiloride family have
been developed as inhibitors of these mem-
brane exchangers, for both basic research and
pharmacological  application  purposes.  The
first  NHE  inhibitor  discovered,  amiloride,  is
capable to inhibit different isoforms of NHE
membrane  proteins,  but  it  is  active  also
against Na+ channels and Na+/Ca2+ exchang-
ers.1 Thereafter, several amiloride derivatives
have  been  developed,  the  most  active  being
obtained by a double substitution on 5-amino
group, leading to the production of DMA, EIPA,
MIBA  and  HMA.  Among  these  novel  deriva-
tives,  HMA  (5-(N,N-hexamethylene)amilo-
ride) is one of the most active, being much
more effective in inhibiting NHEs, while unef-
fective  against  Na+ channels  and  Na+/Ca2+
exchangers.1
Several groups have so far described the bio-
logical effects of HMA focusing on its ability to
induce cell death in cancer cells. In this respect,
it has been demonstrated that HMA administra-
tion to cell cultures results in an intra-cytosolic
acidification and, possibly, activates cell death
through the apoptotic pathway.2-4 Remarkably,
Bourge et al.5 recently demonstrated that the
pro-apoptotic effects of HMA may be triggered
also by an indirect death stimulus involving a
cytosolic  Ca2+ concentration  increase.  These
observations are in line with the results provid-
ed by Park et al.6 who described that HMA trig-
gers  apoptosis  by  depleting  the  endoplasmic
reticulum Ca2+ store. 
In this study, we provide evidence that HMA
gives rise to fluorescence emission. In gener-
al,  molecules  acting  as  fluorophores  can  be
exploited for qualitative and quantitative stud-
ies at cellular level.7 With regard to pharmaco-
logically active molecules, their ability to give
rise to intrinsic fluorescence emission can be
a  powerful  tool  to  directly  investigate  their
presence  and  interaction  with  cells  and  tis-
sues, as to pharmacokinetics, drug subcellular
influx, localization and redistribution, pharma-
cological action and its dependence on defined
cellular  biological  features.  Although  these
kinds of investigations concern mainly photo-
sensitizers,  which  are  molecules  typically
expected  to  exhibit  intrinsic  fluorescence
emission upon suitable excitation,8-13 similar
studies have been reported also for other class-
es of drugs.14-18 In the case of HMA, despite the
evidence  so  far  collected  on  its  biological
effects  likely  leading  to  cell  death,  to  our
knowledge no data are reported in the litera-
ture about the ability of this compound to give
rise to fluorescence emission. The aim of this
work is thus to characterize HMA fluorescence
properties in cultured human ARPE19 cells and
in solution, to provide a basis for an in situ,




HMA (Sigma-Aldrich, Milan, Italy) was dilut-
ed directly from the stock solution (80 mM, in
DMSO) in phosphate buffer (0.1 M, pH 5.0-7.2)
or in serum free cell culture medium to the
final  concentrations  of  80  mM  or  40  mM,
respectively. 
Cell culture and treatments 
Human adult retinal pigmented epithelium -
19 cells (ARPE19) were grown as monolayer at
37°C in humidified atmosphere containing 5%
CO2 in D-MEM/F12 (1:1) medium supplement-
ed with 10% FCS, 4 mM glutamine, 100 U/mL
penicillin  and  0.1  mg/mL  streptomycin  (all
reagents from Celbio, Milan, Italy). Cells were
seeded onto glass coverslips (22-mm diame-
ter) in six-well multiplates at the density of
5ﾥ104 cells/well, 48 h before HMA administra-
tion (40 mM; incubation times ranging from 2
min to 24 h). At the end of each incubation
time,  the  coverslips  were  removed  from  the
medium, rinsed twice with PBS, placed upside
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down  on  a  40  mL  chamber  (Hellma,  Milan,
Italy), mounted on a quartz microscopic slide
and filled with fresh serum free culture medi-
um, to be submitted to imaging or microspec-
trofluorometric  analysis.  Cell  viability  after
irradiation  was  verified  by  means  of  Trypan
blue  (Sigma-Aldrich;  0.4%  in  cell  medium)
exclusion test.
Spectral analysis
Microspectrofluorimetric analysis was per-
formed  in  epiillumination  by  means  of  a
microspectrograph (Leitz, Wetzlar, Germany)
equipped  with  an  Optical  Multichannel
Analyzer (EG&G-PAR, Princeton, USA) with a
512-element  intensified  diode  array  detector
(mod. 1420/512). Excitation light was provided
by a 100 W Hg lamp as excitation source. The
measurement conditions were: 366 nm band-
pass  interference  excitation  filter  (HBW  10
nm, T%366=30) associated with the anti-ther-
mic filters KG1, BG38 to select the excitation
light; TK 390 dichroic mirror, 380 barrier filter,
to select emission light, collected in the 400-
650  nm  spectral  region.  Microspectrofluori-
metric  analysis  was  performed  on  the  HMA
solutions placed in a 40 mL chamber mounted
on a quartz microscopic slide (Hellma, Milan,
Italy) and covered with a coverslip, by means of
a  25ﾥ Leitz  objective  (NA  0.60).  Single  cell
measurements  were  performed  through  the
Leitz microspectrograph by means of a 100x
Leitz  oil  objective  with  an  incorporated  iris
diaphragm (NA 0.60-1.32). To avoid unwanted
photobleaching and/or photoactive effects all
operations were performed under low environ-
mental  light,  and  the  areas  to  be  measured
were selected and focused at microscope under
low  bright  field  illumination.  Acquisition  of
each  spectrum  lasted  2  sec  (10  sequential
scans  of  200  milli-sec  each).  Spectra  were
acquired at time 0 and after 20 sec of continu-
ous  irradiation  (light  fluence  rate=6.35  mW
cm-2 at the focal plane, for a total final dose of
127.00 mJ cm-2). Solutions were irradiated by
exposing them to the light rising from the 100
W  Hg  lamp,  and  selected  by  the  above
described  366  nm  band-pass  interference,
KG1, and BG38 filters, combined with neutral
filters to obtain a light dose at the front of the
quartz cuvette comparable to that applied for
microspectrofluorometry.  Spectra  were
processed  with  the  Savitzky-Golay  algorithm
option  of  the  PeakFitTM program  (Systat
Software Inc., London, UK), with the 10% level
to smooth the noisy data.
Fluorescence imaging 
Fluorescence  images  were  acquired  by
means  of  an  Olympus  BX51  fluorescence
microscope  (Olympus  Optical  Co.  GmBH,
Hamburg, Germany) equipped with a 100 W Hg
excitation lamp and a 4.1 Mpixel digital photo-
camera  (Olympus  Camedia  C-4040  zoom),
operating  under  fixed  aperture  value  and
acquisition time conditions (F=2.6, 1/8 sec).
Images  were  acquired  by  means  of  a  WU
Olympus fluorescence cube (330-385 nm band-
pass excitation filter), FWHM 58 nm, BA420
long-pass barrier filter, named UV conditions.
Images were acquired under the same irradia-
tion  conditions  used  for  microspectrofluoro-
metric analysis. Fluorescence images were col-
lected using a 40ﾥ Olympus UplanFl objective
(NA 0.75).
A Quinine Sulphate solution (1 mM, in 1 N
H2SO4, placed in a 40 mL Hellma chamber) was
used as a reference standard for fluorescence
intensity-based measurement. 
Experiments  were  performed  in  triplicate,
and at least 40 cells were analyzed for each con-
dition, for both spectral and imaging analysis. 
Results and Discussion
Human  ARPE19  cells  observed  at  micro-
scope under UV excitation conditions in the
absence  of  any  drug  incubation  revealed  an
autofluorescence pattern consisting in a faint,
light  bluish  emission,  mainly  located  in  the
cytoplasm, surrounding or overlying the nuclei
(Figure 1A). Continuous irradiation induced a
decrease  of  the  autofluorescence  emission
(Figure 1B). HMA incubation resulted in the
presence of a blue fluorescence in the cyto-
plasm, with a prevailing emission signal local-
ized in the perinuclear polar regions and in
some distinct spots of the cytoplasm, surround-
ing the nuclei characterized by a weaker and
darker blue emission. Comparable subcellular
fluorescence  distribution  patterns  were
observed in cells submitted to HMA incubation
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Figure 1. Patterns of fluorescence emission distribution from ARPE19 cells not treated
with HMA (autofluorescence, A, B), and after incubation with 40 mM HMA for 10 min
(C, D) and 24 h (E, F). Couples of images were taken from the same microscope field at
time 0 (A, C, E) and after 20 seconds (B, D, F) of irradiation under UV excitation condi-
tions. Images are in true colours; autofluorescence images (A, B) were submitted to a 6
times brightness enhancement for presentation. Bar: 40 mm. [page 18] [European Journal of Histochemistry 2012; 56:e3]
for times ranging from few minutes to 24 h
(Figure  1  C-F).  Interestingly,  a  prolonged
observation  of  the  same  microscopic  field
resulted in different effects that appeared to be
dependent  on  the  incubation  time;  no  great
changes occurred in the case of cells incubat-
ed for times shorter than 1 h (Figure 1 C,D),
while an unexpected, marked increase of the
fluorescence emission was observed in cells
incubated with HMA for longer times (Figure 1
E,F). This rising of the fluorescence signal was
particularly evident in the perinuclear region,
and  in  numerous  distinct  spots,  becoming
much brighter than the surrounding cytoplasm
(Figure 1 F). Of note, the effects on HMA emis-
sion properties ascribable to the continuous
irradiation  with  the  excitation  light  were
induced under microscope conventional obser-
vation conditions. No appreciable morphologi-
cal changes indicating cell integrity alteration
were observed in the cells at the end of irradi-
ation, consistently with the absence of stain-
ing following the Trypan blue exclusion test.
The fluorescence emission in HMA treated
cells and possible changes induced by UV irra-
diation were furtherly characterized by means
of microspectrofluorometry. The fluorescence
spectra  recorded  from  single  living  ARPE19
cells  not  treated  with  HMA,  i.e. autofluores-
cence,  or  following  the  drug  administration
showed an emission band in the 420-480 nm
region. The signal amplitude was much lower
in the case of autofluorescence than for HMA
treated cells (Figure 2A). These latter showed
a rising of the emission signal in dependence
of  the  incubation  time,  while  only  small
changes affected the spectral shape, in terms
of a slight narrowing toward the blue region
(Figure 2B). 
The  response  to  irradiation  was  strongly
affected by HMA incubation time. Within few
min of HMA administration, continuous irra-
diation of the same cellular area resulted in a
red shift of the spectral profile (Figure 3A),
which was accompanied by a slight rising in
the  fluorescence  emission  intensity.  For
longer incubation times (from 1 h to 24 h),
irradiation affected in particular the fluores-
cence  emission  intensity,  undergoing  a
marked increase, up to 70%, between meas-
urements at times 0 and 20 sec of irradiation
(Figure 3B). 
Taking  into  account  that  the  biological
effects of HMA are mediated by its ability to
modulate  intracellular  acidity,4 the  fluores-
cence properties of this compound were inves-
tigated in solution, under defined pH condi-
tions. HMA fluorescence features were moni-
tored in phosphate buffer solution in terms of
spectral  shape,  emission  amplitude  and
changes during irradiation.
Fluorescence  spectra  recorded  from  HMA
solution showed a main emission band in the
blue region, peaking at about 430 nm at pH 7.2,
and at 425 nm at pH 5.0. Irradiation induced a
shift  and  a  widening  towards  longer  wave-
lengths of the emission band, which was accom-
panied by an increase in the emission values.
The changes in the spectral shape were favoured
by pH 7.2 in comparison with pH 5.0 (Figure 4
A,B). On the contrary, the emission amplitude
was favoured at pH 5.0, being about 40% higher
than that exhibited by HMA at pH 7.2 already at
time 0, and showing an increase by about 90%
following  6  min  of  irradiation  in  comparison
with the increase of about 10% at pH 7.2.
Conclusions
The  data  obtained  in  solution  confirm  the
noticeable influence of pH conditions on HMA
fluorescence  response  to  irradiation.  On  this
basis, HMA can be considered as a self biomark-
er, exploitable to detect directly its intracellular
effects, in the absence of perturbations from
other pH sensitive dyes. Although a cautionary
note should be required when investigating dif-
ferent organelles in HMA treated cells by means
of specific fluorescent vital-cell dyes, to avoid
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Figure 2. Real scale fluorescence emission spectra recorded from ARPE cells not treated
with HMA (autofluorescence: AF), and from cells incubated with 40 mM HMA for the
times indicated in the figure, at time 0 of irradiation (A). Spectra from HMA incubated
cells, normalized to the peak maximum amplitude (B). Spectra from HMA incubated cells
were corrected for the cell autofluorescence contribution.
Figure 3. Fluorescence emission spectra recorded from ARPE19 cells, incubated with 40
mM HMA for 2 min (A) or 80 min (B). Spectra were corrected for the cell autofluorescence
contribution. Spectra recorded at 0 irradiation time were normalized to 100. Arrows indi-
cate the spectral changes during 366-nm irradiation (times 0, 10, 20 sec). 
Figure 4. Fluorescence emission spectra of 80 mM HMA in phosphate buffer at pH 7.2 (A)
and pH 5.0 (B). Spectra recorded at 0 irradiation time were normalized to 100. Arrows
indicate the spectral changes during irradiation at 366 nm (times 0, 1, 6 min). [European Journal of Histochemistry 2012; 56:e3] [page 19]
overimposition of emission spectra, interesting
perspectives are opened, especially in exploring
at subcellular level the mechanisms underlying,
or regulated by, intracellular pH control in cells
with particular biological properties, e.g. cancer
cells, which are characterized by an extracellu-
lar acidification.19
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